Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for prevention of ulcerative colitis recurrence during corticosteroid tapering
IRCT20121212011738N3Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in autoimmune colitis comparing Montelukast with Placebo (2 arms). Primary endpoints: Remaining in clinical remission and Clinical recurrence. Started Oct 2022; status: completed.
02
Drugs
montelukast
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on IRCT20121212011738N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20121212011738N3.